Track Eli Lilly and Company — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Eli Lilly and Company LLY · Stock Open Eli Lilly and Company in new tab

1443.50 USD
P/E
46.11
EPS
30.81
Yield
0.49%
Safety Score
100
P/B
31.44
ROE
86.02
Beta
0.39
Target Price
1453.40 USD
Eli Lilly and Company logo

Eli Lilly and Company

🧾 Earnings Recap – Q3 2026

Lilly shares rose 6.5% after Q3 revenue grew 39% and the company raised full-year financial guidance. The headline growth was tempered by lower realized prices and roughly $900 million of one-time or estimate-related revenue benefits.

  • Revenue increased 39% year over year; gross margin rose 80 basis points to 84.4%, while the non-GAAP performance margin reached 54.2%, up 5.9 percentage points.
  • Non-GAAP EPS was $7.48, including $4.57 of acquired IPR&D charges; the prior-year quarter was $7.20, including $0.71 of such charges.
  • U.S. revenue grew 34%, primarily on Mounjaro and Zepbound volume, but U.S. price declined 7%—or 10% excluding a favorable rebate-and-discount estimate adjustment.
  • Q3 revenue benefited by approximately $900 million from previously noted items, including a $410 million one-time milestone payment in Europe and the U.S. estimate adjustment.
  • Lilly raised full-year financial guidance; the call also cited continued product launches and pipeline investment, with R&D expense up 23% year over year.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 10, 2027
P/E46.11
EPS30.81
Book Value45.19
Price to Book31.44
Debt/Equity122.93
% Insiders0.161%
Growth
Revenue Growth0.39%
Earnings Growth0.16%
Estimates
Forward P/E28.11
Forward EPS50.54
Target Mean Price1453.40
Dividend
Dividend Yield0.49%
Annual dividends6.69 USD
Ex-Div. DateNov. 13, 2026
Payout21.68%
5y avg Yield1.11%

DCF valuation

Model fair value for Eli Lilly and Company (LLY)
Result
Sign in to run the valuation for LLY.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
29 analysts · consensus Buy · mean target 1453.40 USD (low 940.00, high 1690.00) · as of 11 Nov 2026
Low 940.00
Mean 1453.40
High 1690.00
Price 1443.50
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Eli Lilly and Company Logo Eli Lilly and Company Analysis (LLY)

United States Health Care Official Website Stock

Is Eli Lilly and Company a good investment? Eli Lilly and Company (LLY) is currently trading at 1443.50 USD. Market analysts have a consensus price target of 1453.40 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 46.11. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Eli Lilly and Company is expected to release its next earnings report on Feb. 10, 2027. The market consensus estimate for Forward EPS is 50.54.

For income investors, Eli Lilly and Company pays a dividend yield of 0.49%. With a payout ratio of 22%, the dividend appears sustainable.

Investor FAQ

Does Eli Lilly and Company pay a dividend?

Yes, it pays an annual dividend of 6.69 USD (0.49% yield).

What asset class is Eli Lilly and Company?

Eli Lilly and Company is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 10, 2027. The company currently has a trailing EPS of 30.81.

Company Profile

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss; Olumiant; Omvoh; and Taltz. Further, it provides Emgality for migraine prevention and episodic cluster headache; and Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; BioArctic AB (publ) for new treatment; QurCan Therapeutics Inc for development of PLNP-enabled genetic medicine therapeutics for the treatment of central nervous system and peripheral nervous system; and Abbisko Therapeutics for discovery and development of medicines across multiple targets. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Exchange Ticker
GER (Germany) LLY.DE
EBS (Ireland) LLY.SW
FRA (Germany) LLY.F
MEX (Mexico) LLY.MX
STU (Germany) LLY.SG
NYQ (United States) LLY
BUE (Argentina) LLY.BA
Trades
Dividend Yield
0.49%
5y avg 1.11%
Annual Dividends
6.69USD
Next Ex. Div Date
Nov. 13, 2026
Payout Ratio
21.68%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
5.98 USD
Sept. 10, 2027 (estimated) 1.9917
June 10, 2027 (estimated) 1.9917
March 10, 2027 (estimated) 1.9917
▸2026
6.92 USD
Dec. 10, 2026 1.7300
Sept. 10, 2026 1.7300
June 10, 2026 1.7300
March 10, 2026 1.7300
▸2025
6.00 USD
Dec. 10, 2025 1.5000
Sept. 10, 2025 1.5000
June 10, 2025 1.5000
March 10, 2025 1.5000
▸2024
5.20 USD
Dec. 10, 2024 1.3000
Sept. 10, 2024 1.3000
June 10, 2024 1.3000
March 8, 2024 1.3000
▸2023
4.52 USD
Dec. 8, 2023 1.1300
Sept. 8, 2023 1.1300
June 9, 2023 1.1300
March 10, 2023 1.1300
▸2022
3.92 USD
Dec. 9, 2022 0.9800
Sept. 9, 2022 0.9800
June 10, 2022 0.9800
March 10, 2022 0.9800
▸2021
3.40 USD
Dec. 10, 2021 0.8500
Sept. 10, 2021 0.8500
June 10, 2021 0.8500
March 10, 2021 0.8500
▸2020
2.96 USD
Dec. 10, 2020 0.7400
Sept. 10, 2020 0.7400
June 10, 2020 0.7400
March 10, 2020 0.7400
▸2019
2.58 USD
Dec. 10, 2019 0.6450
Sept. 10, 2019 0.6450
June 10, 2019 0.6450
March 8, 2019 0.6450
▸2018
2.25 USD
Dec. 10, 2018 0.5630
Sept. 10, 2018 0.5630
June 8, 2018 0.5630
March 9, 2018 0.5630
▸2017
2.08 USD
Dec. 8, 2017 0.5200
Sept. 8, 2017 0.5200
June 9, 2017 0.5200
March 10, 2017 0.5200
▸2016
2.04 USD
Dec. 9, 2016 0.5100
Sept. 9, 2016 0.5100
June 10, 2016 0.5100
March 10, 2016 0.5100
▸2015
2.00 USD
Dec. 10, 2015 0.5000
Sept. 10, 2015 0.5000
June 10, 2015 0.5000
March 10, 2015 0.5000
▸2014
1.96 USD
Dec. 10, 2014 0.4900
Sept. 10, 2014 0.4900
June 10, 2014 0.4900
March 10, 2014 0.4900
▸2013
1.96 USD
Dec. 10, 2013 0.4900
Sept. 10, 2013 0.4900
June 10, 2013 0.4900
March 8, 2013 0.4900
▸2012
1.96 USD
Dec. 10, 2012 0.4900
Sept. 10, 2012 0.4900
June 8, 2012 0.4900
March 9, 2012 0.4900
▸2011
1.96 USD
Dec. 9, 2011 0.4900
Sept. 9, 2011 0.4900
June 10, 2011 0.4900
March 10, 2011 0.4900
▸2010
1.96 USD
Dec. 10, 2010 0.4900
Sept. 10, 2010 0.4900
June 10, 2010 0.4900
March 10, 2010 0.4900
▸2009
1.96 USD
Dec. 10, 2009 0.4900
Sept. 10, 2009 0.4900
June 10, 2009 0.4900
March 10, 2009 0.4900
▸2008
1.88 USD
Dec. 10, 2008 0.4700
Sept. 10, 2008 0.4700
June 10, 2008 0.4700
March 10, 2008 0.4700
▸2007
1.70 USD
Dec. 10, 2007 0.4250
Sept. 10, 2007 0.4250
June 8, 2007 0.4250
March 9, 2007 0.4250
▸2006
1.60 USD
Dec. 8, 2006 0.4000
Sept. 8, 2006 0.4000
June 9, 2006 0.4000
March 10, 2006 0.4000
▸2005
1.52 USD
Dec. 9, 2005 0.3800
Sept. 9, 2005 0.3800
June 10, 2005 0.3800
March 10, 2005 0.3800
▸2004
1.42 USD
Dec. 10, 2004 0.3550
Sept. 10, 2004 0.3550
June 10, 2004 0.3550
March 10, 2004 0.3550
▸2003
1.34 USD
Dec. 10, 2003 0.3350
Sept. 10, 2003 0.3350
June 10, 2003 0.3350
March 10, 2003 0.3350
▸2002
1.24 USD
Dec. 10, 2002 0.3100
Sept. 10, 2002 0.3100
June 10, 2002 0.3100
March 8, 2002 0.3100
▸2001
1.12 USD
Dec. 10, 2001 0.2800
Sept. 10, 2001 0.2800
June 11, 2001 0.2800
March 9, 2001 0.2800
▸2000
1.04 USD
Dec. 11, 2000 0.2600
Sept. 11, 2000 0.2600
June 9, 2000 0.2600
March 10, 2000 0.2600
▸1999
0.92 USD
Dec. 10, 1999 0.2300
Sept. 10, 1999 0.2300
June 10, 1999 0.2300
March 10, 1999 0.2300
▸1998
0.80 USD
Dec. 10, 1998 0.2000
Sept. 10, 1998 0.2000
June 10, 1998 0.2000
March 10, 1998 0.2000
▸1997
1.28 USD
Dec. 10, 1997 0.2000
Sept. 10, 1997 0.3600
June 10, 1997 0.3600
March 10, 1997 0.3600
▸1996
1.37 USD
Dec. 10, 1996 0.3425
Sept. 10, 1996 0.3425
June 10, 1996 0.3425
March 11, 1996 0.3425
▸1995
2.62 USD
Dec. 11, 1995 0.6850
Sept. 11, 1995 0.6450
June 12, 1995 0.6450
March 10, 1995 0.6450
▸1994
2.50 USD
Dec. 12, 1994 0.6250
Sept. 12, 1994 0.6250
June 10, 1994 0.6250
March 10, 1994 0.6250
▸1993
2.42 USD
Dec. 10, 1993 0.6050
Sept. 10, 1993 0.6050
June 10, 1993 0.6050
March 10, 1993 0.6050
▸1992
2.20 USD
Dec. 10, 1992 0.5500
Sept. 10, 1992 0.5500
June 10, 1992 0.5500
March 10, 1992 0.5500
▸1991
2.00 USD
Dec. 10, 1991 0.5000
Sept. 10, 1991 0.5000
June 8, 1991 0.5000
March 9, 1991 0.5000
▸1990
1.64 USD
Dec. 8, 1990 0.4100
Sept. 8, 1990 0.4100
June 9, 1990 0.4100
March 10, 1990 0.4100
▸1989
1.69 USD
Dec. 9, 1989 0.3370
Sept. 9, 1989 0.3370
June 10, 1989 0.3370
March 10, 1989 0.6750
▸1988
2.30 USD
Dec. 10, 1988 0.5750
Sept. 10, 1988 0.5750
June 10, 1988 0.5750
March 10, 1988 0.5750
▸1987
2.00 USD
Dec. 10, 1987 0.5000
Sept. 10, 1987 0.5000
June 10, 1987 0.5000
March 10, 1987 0.5000
▸1986
1.80 USD
Nov. 7, 1986 0.4500
Aug. 11, 1986 0.4500
May 9, 1986 0.4500
Feb. 10, 1986 0.4500
▸1985
3.20 USD
Nov. 8, 1985 0.8000
Aug. 9, 1985 0.8000
May 9, 1985 0.8000
Feb. 8, 1985 0.8000
▸1984
2.98 USD
Nov. 8, 1984 0.8000
Aug. 9, 1984 0.7250
May 9, 1984 0.7250
Feb. 8, 1984 0.7250
▸1983
2.75 USD
Nov. 7, 1983 0.7250
Aug. 9, 1983 0.7250
May 9, 1983 0.6500
Feb. 9, 1983 0.6500
▸1982
2.60 USD
Nov. 5, 1982 0.6500
Aug. 9, 1982 0.6500
May 10, 1982 0.6500
Feb. 8, 1982 0.6500
▸1981
2.30 USD
Nov. 6, 1981 0.5750
Aug. 10, 1981 0.5750
May 11, 1981 0.5750
Feb. 5, 1981 0.5750
▸1980
2.20 USD
Nov. 7, 1980 0.5750
Aug. 11, 1980 0.5750
May 12, 1980 0.5250
Feb. 8, 1980 0.5250
▸1979
1.95 USD
Nov. 2, 1979 0.5250
Aug. 6, 1979 0.5250
May 7, 1979 0.4500
Feb. 5, 1979 0.4500
▸1978
1.65 USD
Nov. 3, 1978 0.4500
Aug. 7, 1978 0.4000
May 8, 1978 0.4000
Feb. 6, 1978 0.4000
▸1977
1.42 USD
Nov. 3, 1977 0.3550
Aug. 8, 1977 0.3550
May 9, 1977 0.3550
Feb. 4, 1977 0.3550
▸1976
1.25 USD
Nov. 5, 1976 0.3250
Aug. 9, 1976 0.3250
May 10, 1976 0.3000
Feb. 6, 1976 0.3000
▸1975
1.10 USD
Nov. 7, 1975 0.2750
Aug. 11, 1975 0.2750
May 12, 1975 0.2750
Feb. 7, 1975 0.2750
▸1974
0.97 USD
Nov. 8, 1974 0.2500
Aug. 12, 1974 0.2500
May 13, 1974 0.2350
Feb. 8, 1974 0.2350
▸1973
0.79 USD
Nov. 12, 1973 0.2070
Aug. 13, 1973 0.2070
May 14, 1973 0.1890
Feb. 9, 1973 0.1890
▸1972
0.36 USD
Nov. 13, 1972 0.1820
Aug. 7, 1972 0.1820
Upcoming Dividends
Name Payment Date Status Amount
Eli Lilly and Company Dec 10, 2026 Upcoming 1.73 USD
Eli Lilly and Company Sep 10, 2026 1.73 USD
Eli Lilly and Company Jun 10, 2026 1.73 USD
Eli Lilly and Company Mar 10, 2026 1.73 USD
Stock Splits
Split Date Split Ratio to 1
Jan. 30, 1986 2:1
May 1, 1989 2:1
Dec. 21, 1995 2:1
Oct. 16, 1997 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion